The FDA-approved smoking cessation pill, varenicline, has emerged as a powerful ally in the fight against vaping addiction among teens and young adults.Recent research from Mass General Brigham suggests that this twice-daily medication significantly increases the likelihood of successfully quitting vaping, with participants experiencing more than three times the success rate compared to those on placebo.